在儿童中成功使用瑞桑基祖马布治疗皮病Rubra Pilaris

Marta Kołt-Kamińska1, Antonina Osińska2, Ewa Kaznowska3

  • 1Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Szopena 2, 35-055, Rzeszów, Poland.

Dermatology and therapy
|September 13, 2023
PubMed
概括

皮疹 (Pityriasis rubra pilaris,简称PRP) 是一种罕见的皮肤疾病. 作为一种IL-23抑制剂的瑞桑基祖马布 (risankizumab) 有效且安全地治疗了三名患有严重PRP的儿科患者,这些患者对其他疗法没有反应.